Abstract Imidazolium-based ionic liquids (ILs) were designed and synthesised for their use as non-conventional media in alcohol dehydrogenase (ADH)-catalysed reactions. Screenings with several ADHs and various ketone or alcohol substrates for their selective reductions or oxidations, respectively, showed that when containing up to 50 % of the IL the overall conversion of the reactions could be improved in some cases, while the stereoselectivity of the enzyme remained unaltered. Attempts at using these ILs as co-substrates for the recycling of the nicotinamide cofactor led to promising results, opening a new possibility for a substrate-coupled recycling system.
Introduction
Enzyme-catalysed redox reactions have gained major attention in recent years for the production of enantiopure compounds, whether used for pharmaceutical purposes or in industrial processes, due to the high selectivity, mild reaction conditions and lower environmental impact displayed with oxidoreductases [1] . In particular, alcohol dehydrogenases (ADHs, NAD-dependent EC 1.1.1.1 and NADP-dependent EC 1.1.1.2) perform stereoselective carbonyl reductions and enantioselective alcohol oxidations [2] [3] [4] [5] [6] [7] [8] . Enantiopure chiral secondary alcohols are commonly used in the pharmaceutical and food industry as well as for flavour, fragrances and liquid crystals [9, 10] . These high added-value compounds can be synthesised by the asymmetric reduction of the corresponding prochiral ketones using several methods, thus affording a 100 % theoretical yield of the enantiopure product. Metal-catalysed hydrogenation [11] , hydrosilylation [12] , and hydrogen-transfer (Meerwein-Ponndorf-Verley reduction) [13] [14] [15] reactions are the most commonly used strategies to selectively and catalytically reduce ketones. On the other hand oxidation processes can also provide the enantiopure alcohols, albeit with a maximum yield of 50 % through kinetic resolution. In this context, the metal-catalysed Oppenauer oxidation can be seen as a complementary methodology to the ADH protocols. Nevertheless, these chemical routes still present several drawbacks mainly emerging from an environmental point of view with the presence of toxic reagents and harsh reaction conditions. Alternatively, the use of ADHs to perform redox reactions, which has been extensively studied in past years [1] [2] [3] [4] [5] [6] [7] [8] , generally appears as a greener synthetic pathway, thus giving rise to valuable industrial applications [16] [17] [18] [19] .
ADHs catalyse redox reactions through a well-known mechanism involving the nicotinamide cofactor NAD(P)H. Common challenges encountered with their use include substrate solubility, product recovery and costly NAD(P)H unless a regeneration system is employed. In principle, an ideal cofactor recycling method should meet the following criteria: (i) stable and inexpensive enzymes, (ii) high specific enzymatic activity, (iii) simple and inexpensive reagents that do not interfere with the isolation of the desired product or with the stability of the enzyme, (iv) high turnover number, and (v) a reachable favourable equilibrium for product formation [20] . The most important strategies that have been developed for the in situ regeneration of nicotinamide cofactors with ADHs are: (i) using another enzyme or co-substrate in an ''enzyme-coupled'' or ''substrate-coupled'' system, (ii) engineering whole cells to overexpress both the ADH and the cofactor regenerating enzyme, (iii) electrochemical, and (iv) chemical [21] [22] [23] [24] [25] [26] . Among all these methodologies, the ''substrate-coupled'' system is highly convenient for economic reasons. In this case, the same enzyme transforms the substrate of interest and recycles the cofactor at the expense of a cheap cosubstrate such as 2-propanol or acetone. Due to the reversibility of ADH-catalysed reactions, a large molar excess of the co-substrate is often added to shift the equilibrium.
Ionic Liquids (ILs) in ADH-Catalysed Reactions
ILs have been increasingly used in homogeneous, heterogeneous and biocatalysis [27] . The use of ILs in biotransformations is still expanding to enzymes such as oxidoreductases [28] [29] [30] [31] [32] [33] [34] . In this manner, to increase the solubility of hydrophobic substrates and improve the biocatalytic yield by minimising the substrate or product inhibition, organic solvents and ILs can be used: (i) as cosolvents with the aqueous medium, (ii) as a second phase in a biphasic system or (iii) alone as non-aqueous solvents (e.g. with lipases). However, organic solvents and ILs can inhibit or inactivate the enzyme at high concentrations. Mainly, biphasic systems have been applied with oxidoreductases [35] . Thus, the organic phase contains the hydrophobic substrates, whereas the aqueous phase contains the enzyme(s) and cofactor(s). Notwithstanding, adding organic solvents or ILs (imidazolium or aminobased) can sometimes increase the enzyme activity, stability and stereoselectivity in specific examples with certain enzymes [36] [37] [38] .
For instance, an extensive study has been performed on the stability of ADH-A (from Rhodococcus ruber) with various amounts of IL, demonstrating that ADH-A can in fact resist high concentrations of IL and afford reasonable conversions, especially with those that are hydroxy-functionalised [36] . Additionally, LBADH (from Lactobacillus brevis) has been used in the presence of several watermiscible ILs to reduce hardly water-soluble ketones such as 2-nonanone and 2-decanone, and also with an IL in a twophase system to efficiently achieve the bioreduction of 2-octanone due to favourable partition coefficients of the co-substrate (2-propanol) utilised and the co-product (acetone) obtained [39, 40] . More importantly, the use of these co-solvents has led to the development of efficient systems to obtain high added-value compounds in a selective manner [41] [42] [43] .
In this study we envisioned the regeneration of the nicotinamide cofactors in ADH-catalysed redox reactions using imidazolium-based ILs as non-conventional media and also as co-substrates. As previous results have shown that ADHs can be highly stable with hydroxy-functionalised ILs [36] , the synthesis of water-miscible hydroxylated imidazole-based ILs was envisaged to use them as: (i) an appropriate co-solvent for the enzymatic reactions, allowing the use of higher substrate concentrations and a simpler recovery of the final products from the reaction mixture through extraction, and (ii) as a possible co-substrate for the ADH-catalysed transformations, allowing its reuse over several cycles and avoiding the employment or formation of 2-propanol that could interfere in the purification of interesting volatile products (Scheme 1).
Therefore, 1-(2-hydroxypropyl)-3-methylimidazolium chloride (IL 1) and 3-methyl-1-(2-oxopropyl)imidazolium chloride (IL 2) were chosen to achieve these goals. In a first set of experiments, 2-propanol or acetone were used as cosubstrates and the IL as an additive to observe whether the latter affected the enzymatic reaction outcome. These ILs were also chosen based on their straightforward synthesis without purification. Additionally, the chloride anion is (i) smaller than a bromide, (ii) makes the IL more soluble in an aqueous medium such as buffer, contrarily to other anions (e.g. NTf 2 , BF 4 ), and (iii) provides a stable IL, as opposed to other anions (e.g. PF 6 ). IL 1 was simply obtained from commercially available N-methyl imidazole (3) with hydrochloric acid in ethanol at 0°C and propylene oxide (4, Scheme 2) [44] . The product was obtained pure after several washes with diethyl ether to remove the excess of 3.
IL 2 was obtained through the nucleophilic substitution of freshly distilled chloroacetone (5) with 3 at -20°C (Scheme 3) [45] . Again, the only purification required was an extraction with diethyl ether to remove any excess of 3.
ADH-Catalysed Bioreductions with IL 1
Once synthesised, the effect of these ILs was studied in several ADH-catalysed bioreduction processes with commercially available and overexpressed enzymes. The following enzymes were used in this study: ADH-A from Rhodococcus ruber, LBADH from Lactobacillus brevis, LKADH from Lactobacillus kefir, RasADH from Ralstonia sp., SyADH from Sphingobium yanoikuyae, TeSADH from Thermoanaerobacter ethanolicus, ADH-T from Thermoanaerobium sp. and CPADH from Candida parapsilosis (see Supporting Information for more details), and for each of them a model substrate was used in order to understand the influence of the ILs in the enzyme reactivity. Data are collected in Table 1 The other ADHs, especially E. coli/SyADH, fared less well, negatively affected by the presence of this IL. Moreover, the excellent stereoselectivities shown by all the biocatalysts in these processes remained unchanged even at high concentrations of IL 1. Next, the reactions affording the best results were run in the absence of isopropanol or G6P/ G6PDH, therefore with IL 1 as the sole potential hydrogen donor for NAD(P)H recycling (Table 2) .
Unfortunately, IL 1 was not suitable as a co-substrate for these ADHs to recycle NAD(P)H, affording close to no conversion (entries 2-5). Nevertheless, in the blank reaction without IL, 4 % of the alcohol was obtained (entry 1). This value can be explained by the added cofactor (1 mM) in combination with the known presence of NAD(P)H in the E. coli cells, thus allowing the reduction reaction. This observation was confirmed when running the reactions without the addition of any external nicotinamide cofactor (Table 3 , entries 1 and 3). Indeed, with the addition of a proper hydrogen donor source such as 2-propanol (entries 11-15), high conversions of the enantiopure products could be attained without any additional external nicotinamide cofactor.
With the promising results seen in Table 1 with IL 1 as co-solvent in the ADH-catalysed bioreductions, attempts to increase the substrate concentration were made, using E. coli/ADH-A and E. coli/RasADH in the presence or absence of the IL. The IL maintained or increased the conversion up to 200 mM substrate concentration with E. coli/ADH-A (Graph 1), whereas with E. coli/RasADH the IL was beneficial up to a substrate concentration of 400 mM (Graph 2).
ADH-Catalysed Biooxidations with IL 2
Subsequently, the opposite biooxidations of various secondary alcohols were studied with several ADHs using acetone as co-substrate at varying amounts of IL 2, first employed as co-solvent (Table 4) . With a maximum conversion of 50 % due to the high stereospecificity of the studied enzymes, excellent conversions were again observed with 10 and 20 % w/v of IL 2 when combined with ADH-A, LBADH, ADH-T and CPADH, maintaining the excellent selectivity (entries 2, 3, 7, 8, 11, 12, 27 and 31). More importantly, although in some cases 50 % w/v of this IL still gave an attractive conversion (entries 4 and 13), 2 appeared to be more toxic for the enzymes since overall lower enzymatic activities were obtained in comparison with IL 1. LKADH and E. coli/RasADH are known to perform poorly with acetone as a co-substrate, and thus as expected did not afford any conversion (entries [15] [16] [17] [18] . Similarly as for IL 1, the oxidation reactions were achieved in the absence of acetone to study the role of IL 2 as cosubstrate (Table 5) . These results at first appeared promising, since in all cases, and especially with E. coli/ADH-A, moderate to excellent conversions and ee were obtained even at 20 % w/v of IL 2. Surprisingly, upon closer inspection, the blank biooxidation reactions with E. coli/ADH-A lyophilised cells without IL and acetone, also afforded 50 % conversion (entry 1), providing the remaining (R)-1-phenylethanol (6b) with[99 % ee. Consequently, the conversions obtained with the overexpressed ADHs would be biased due to the ability of the lyophilised E. coli cells to internally regenerate the cofactor [46] . For E. coli/TeSADH and E. coli/ADH-T, adding IL 2 actually decreased the conversion compared to the blank reactions (entries 8 and 10). The only positive result obtained using IL 2 as a hydrogen acceptor was with commercially available LBADH (entries 4-6). Thus, in the presence of 20 % w/v of IL 2, the reaction afforded 22 % of acetophenone (6a) and 27 % ee for the remaining (S)-1-phenylethanol (6b). Nonetheless, IL 2 appeared to scarcely regenerate the cofactor with CPADH (entries 12 and 13), affording only 2 % of 8b without IL 2 in the presence of the cofactor, while obtaining 6 % of conversion with 20 % w/v of IL 2 present in the reaction. 3 was envisaged (Scheme 4). Previous results with this catalyst have shown that when using 2-propanol for the reduction of ketones (Scheme 4a), or acetone for the oxidation of secondary alcohols, similar conversions to that observed with LBADH and ADH-A as biocatalysts were achieved [47] .
Hence, whereas the reduction of 6a to 6b using 2-propanol as co-substrate with the aluminium catalyst afforded 86 % of conversion, in the same reaction conditions with IL 1 only 7 % of conversion was achieved (Scheme 4b). IL 1 was therefore not efficient to perform hydrogen transfer reactions, which would explain the poor results obtained in the ADH-catalysed reactions as well.
Due to the possible steric hindrance of the imidazole core in 1, another IL with an additional methylene group to avoid having the imidazole ring at the a-position was envisaged as possible hydrogen donor in this aluminiumcatalysed system (IL 12, Scheme 5). As the ketone obtained from imidazole (9) and methyl vinyl ketone (10) was unstable (retro-Michael reaction), the hydroxylated derivative 11 was directly produced by in situ reduction of the carbonyl group with NaBH 4 at 0°C with an overall yield of 78 % for both steps. The imidazole ring was then methylated with hydrochloric acid and dimethylcarbonate, affording IL 12 in 55 % yield. Unfortunately, when performing the reduction of ketone 6a to produce alcohol 6b with the aluminium catalyst, the conversion did not surpass 7 %, demonstrating that these derivatives seem to act as poor hydrogen donors or acceptors.
Conclusions
Imidazolium-based ILs were synthesised and used, first as co-solvents, and then as co-substrates in ADH-catalysed redox reactions employing a ''coupled-substrate'' approach. Although these ILs did not prove to be suitable hydrogen donors/acceptors, they were successfully used in bioreduction and biooxidation reactions as co-solvents. Best results were attained in the bioreduction of prochiral ketones with a broad range of ADHs and hydroxylated IL 1 leading to comparable or higher conversions with respect to the reactions carried out in aqueous medium, even up to 50 % w/v IL concentration, thus enabling the use of higher substrate loadings (up to 200 mM for ADH-A and 400 mM for RasADH) without any detrimental effect on the enzyme selectivity. Interestingly, carbonylic IL 2 could be accepted to some extent by LBADH as hydrogen acceptor for the biooxidation of 1-phenylethanol. Although still in a preliminary phase, these results are a promising starting point to obtain novel derivatives that could be better accepted by ADHs and other redox enzymes.
